Partnership improves access to great dermatologic care Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence into the state of South Carolina through …
Free to Join, Customers can Gear Up and Get Rewarded with the Enhanced Points-Based Loyalty Program NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Adorama, the trusted source for market-leading photo, video, audio, computer equipment and information, is excited to …
CHARLOTTE, N.C., Nov. 7, 2022 /PRNewswire/ -- Madison Communities, an affiliate of Madison Capital Group, has recently broken ground on 288 units located in the West Charlotte Submarket at the corner of Wilkinson and West Morehead in Charlotte. …
The construction industry is taking on new life with the integration and automation of data within construction projects. Team D3 is bringing their decades of AECO and manufacturing expertise to the table to improve and revolutionize the construction …
Su-vastika's focus is on designing the Automatic Testing Equipment for testing Electric Vehicles so that we are able to help the Electric Vehicle Industry to test all the parameters to ensure the reliability of Electric Vehicles. There is no denying …
ST. JOHN'S, NL, Nov. 7, 2022 /CNW/ - The Honourable Joyce Murray, Minister of Fisheries, Oceans and the Canadian Coast Guard welcomes Indigenous partners, the commercial fishing industry, provincial governments and other stakeholders to discuss …
NEWTOWN, Pa., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the …
New York, US, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Automotive Suspension System Market Overview According to a comprehensive research report by Market Research Future (MRFR), "Automotive Suspension System Market Research Report Information By Suspension …
DUBLIN, Nov. 7, 2022 /PRNewswire/ -- The "Utility Locator Market by Technique (Electromagnetic Field, GPR), Offering (Equipment and Services), Target (Metallic Utilities and Non-Metallic Utilities), Vertical (Oil & Gas, Electricity, Transportation …
PITTSBURGH, Nov. 7, 2022 /PRNewswire/ -- "I'm a registered nurse and I thought there could be a better incontinence product for patients," said an inventor, from San Diego, Calif., "so I invented the INCONTINENCE PRODUCT. My design could …
Please note that the media advisory published on November 7, 2022, has been modified. See the corrected version below. ROUYN-NORANDA, QC, Nov. 7, 2022 /CNW Telbec/ - Canada Economic Development for Quebec Regions (CED) The Minister of Sport and Minister …
SEOUL, South Korea, Nov. 07, 2022 (GLOBE NEWSWIRE) -- 3Dme Crown of Imagoworks Inc., a digital dental CAD solution company based on artificial intelligence, is attracting attention as the next-generation dental CAD. 3Dme Crown is an automatic crown design …
NEWARK, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will …
BALA CYNWYD, Pa., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that company management will …
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), a pioneer in data security and analytics, announced its participation at the following upcoming conferences: The 16th Annual Needham Virtual Security, Networking, & …
DUBLIN, Ireland, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant …
Initial Phase 1b data for three ongoing clinical studies expected to be reported in 1H 2023: ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2-mutated cancers, and ORIC-944 in prostate cancer Ongoing clinical development of ORIC-114 expanded with FDA …
Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers Simplifies biomarker assay development and validation Creates end-to-end spatial phenotyping workflow …
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Pegasus Merger Co. (the “Company”), an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc., announced today that it has amended the terms of the Company’s previously …
04 days 00:33:59
